FILINGS
| PIRS 0001583648 | |||
|---|---|---|---|
| Filing Date | Form Type | Description | Document |
| 2025-01-17 | 424B3 | FORM 424B3 | View Document |
| 2025-01-16 | EFFECT | View Document | |
| 2025-01-14 | S-1/A | FORM S-1/A | View Document |
| 2025-01-13 | 8-K | FORM 8-K | View Document |
| 2025-01-08 | SCHEDULE 13G | View Document | |
| 2025-01-06 | 3/A | AMENDED INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-31 | S-1 | FORM S-1 | View Document |
| 2024-12-20 | SCHEDULE 13D | View Document | |
| 2024-12-20 | SCHEDULE 13G | View Document | |
| 2024-12-20 | SCHEDULE 13G | View Document | |
| 2024-12-19 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-17 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-17 | 4 | OWNERSHIP DOCUMENT | View Document |
| 2024-12-17 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | View Document |
| 2024-12-17 | SCHEDULE 13G/A | View Document | |
| 2024-12-16 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-16 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-16 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-16 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-16 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-16 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-16 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-16 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2024-12-16 | 4 | PRIMARY DOCUMENT | View Document |
| 2024-12-16 | 8-K | FORM 8-K | View Document |
| 2024-12-12 | 4 | FORM 4 (GERAGHTY SERIES F) | View Document |
| 2024-12-12 | 425 | FORM 425 | View Document |
| 2024-12-12 | 8-K | FORM 8-K | View Document |
| 2024-12-09 | 4 | FORM 4 (ANNUAL GRANT) | View Document |
| 2024-12-06 | SCHEDULE 13G/A | View Document | |
| 2024-12-03 | 425 | FORM 425 | View Document |
| 2024-12-03 | 8-K | FORM 8-K | View Document |
| 2024-11-18 | 3 | PRIMARY DOCUMENT | View Document |
| 2024-11-14 | SC 13G/A | PIERIS PHARMACEUTICALS, INC. | View Document |
| 2024-11-13 | 10-Q | FORM 10-Q | View Document |
| 2024-11-12 | SEC STAFF LETTER | View Document | |
| 2024-11-08 | EFFECT | View Document | |
| 2024-11-08 | 424B3 | FORM 424B3 | View Document |
| 2024-11-07 | 425 | FORM 425 | View Document |
| 2024-11-07 | CORRESP | View Document | |
| 2024-11-07 | S-4/A | FORM S-4/A | View Document |
| 2024-11-06 | DEF 14A | FORM DEF 14A | View Document |
| 2024-11-06 | ARS | FORM ARS | View Document |
| 2024-11-05 | CORRESP | View Document | |
| 2024-11-05 | S-4/A | FORM S-4/A | View Document |
| 2024-11-04 | UPLOAD | View Document | |
| 2024-10-29 | CORRESP | View Document | |
| 2024-10-29 | S-4/A | FORM S-4/A | View Document |
| 2024-10-28 | 4 | FORM 4 (SERIES F) | View Document |
| 2024-10-25 | SEC STAFF LETTER | View Document | |
| 2024-10-25 | UPLOAD | View Document | |
| 2024-10-17 | 425 | FORM 425 | View Document |
| 2024-10-15 | CORRESP | View Document | |
| 2024-10-15 | S-4/A | FORM S-4/A | View Document |
| 2024-10-15 | 425 | FORM 425 | View Document |
| 2024-10-09 | UPLOAD | View Document | |
| 2024-10-03 | 425 | FORM 425 | View Document |
| 2024-10-03 | 8-K | FORM 8-K | View Document |
| 2024-09-23 | CORRESP | View Document | |
| 2024-09-23 | S-4/A | FORM S-4/A | View Document |
| 2024-09-06 | UPLOAD | View Document | |
| 2024-08-14 | 10-Q | FORM 10-Q | View Document |
| 2024-08-12 | 4 | PRIMARY DOCUMENT | View Document |
| 2024-08-09 | S-4 | FORM S-4 | View Document |
| 2024-08-08 | 425 | FORM 425 | View Document |
| 2024-08-08 | 8-K | FORM 8-K | View Document |
| 2024-08-07 | SCHEDULE 13G | View Document | |
| 2024-08-01 | SC 13G | SC 13G | View Document |
| 2024-07-31 | 3 | PRIMARY DOCUMENT | View Document |
| 2024-07-24 | 425 | FORM 425 | View Document |
| 2024-07-24 | 8-K | FORM 8-K | View Document |
| 2024-07-03 | 8-K | FORM 8-K | View Document |
| 2024-05-17 | SC 13G | THE SCHEDULE 13G | View Document |
| 2024-05-17 | SC 13G | THE SCHEDULE 13G | View Document |
| 2024-05-15 | 10-Q | FORM 10-Q | View Document |
| 2024-05-09 | 8-K | FORM 8-K | View Document |
| 2024-04-29 | 10-K/A | FORM 10-K/A | View Document |
| 2024-04-18 | 8-K | FORM 8-K | View Document |
| 2024-03-29 | 10-K | FORM 10-K | View Document |
| 2024-03-27 | 8-K | FORM 8-K | View Document |
| 2024-02-14 | SC 13G/A | View Document | |
| 2024-02-14 | SC 13G/A | View Document | |
| 2024-02-14 | SC 13G/A | PIERIS PHARMACEUTICALS, INC. | View Document |
| 2024-02-02 | SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | View Document |
| 2023-12-21 | 8-K | FORM 8-K | View Document |
| 2023-11-14 | 10-Q | FORM 10-Q | View Document |
| 2023-08-31 | 8-K/A | FORM 8-K/A | View Document |
| 2023-08-17 | SC 13D/A | AMENDMENT NO. 1 TO THE SCHEDULE 13D | View Document |
| 2023-08-10 | S-8 | S-8 | View Document |
| 2023-08-10 | 10-Q | FORM 10-Q | View Document |
| 2023-07-18 | 8-K | FORM 8-K | View Document |
| 2023-07-13 | 8-K | FORM 8-K | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.
